12/4
02:02 pm
mrus
Merus N.V. (MRUS): A Bull Case Theory [Yahoo! Finance]
Low
Report
Merus N.V. (MRUS): A Bull Case Theory [Yahoo! Finance]
11/17
07:10 am
mrus
Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab [Yahoo! Finance]
Low
Report
Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab [Yahoo! Finance]
10/31
10:07 am
mrus
Merus (NASDAQ:MRUS) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets.
Low
Report
Merus (NASDAQ:MRUS) had its "market perform" rating reaffirmed by analysts at BMO Capital Markets.
10/25
12:09 pm
mrus
Merus (NASDAQ:MRUS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Merus (NASDAQ:MRUS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/24
10:00 am
mrus
Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety
Low
Report
Merus’ Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety
10/23
12:43 pm
mrus
Merus Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS
Low
Report
Merus Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS